Rxwire
In the news · 48h FDA 39 Eli Lilly 19 Roche 9 Merck & Co. (MSD) 8 Johnson & Johnson 4 AbbVie 3 AstraZeneca 3 Novo Nordisk 3
Approvals & regulatory · first seen yesterday, updated yesterday

Persista Bio Receives Positive Feedback on Modular Approach from FDA INTERACT

1 outlet CAR-T & cell therapy FDA

—Increased confidence on cell therapy system approach for Type 1 diabetes ITHACA, N.Y., Sept. 23, 2026 /PRNewswire/ -- Through a recent INTERACT meeting with the Food and Drug Administration Center for Biologics Evaluation and Research (CBE…

Summary from PR Newswire - FDA Approval.

Coverage 1 article · 1 outlet

  1. PR Newswire - FDA Approval
    Persista Bio Receives Positive Feedback on Modular Approach from FDA INTERACT